"No Comment" On Annotated 483s Deemed Ambiguous By Firms At PDA
Executive Summary
"No comment" responses on annotated FDA-483 forms are ambiguous and leave companies with questions as to how the term is interpreted, industry representatives said Dec. 1 at the PDA annual meeting in Washington, D.C.